MCIF Lab - Cyclotron and Radiopharmaceutical Research and Development Facility
  • Home
  • Facilities
  • Services
  • NEWS AND EVENTS
  • People
  • Contact us

Our Services

MCIF can provide investigators with:
  • Novel theranostic agents to provide molecular-level targeted radiotherapy
  • Diagnostic PET/SPECT probes to support in-vivo therapy response studies (imaging/bio-d*)
  • Custom radiolabeled analogues of novel therapeutics, providing in-vivo drug behavior data via PET/SPECT imaging* and bio-d*
  • Translation of non-radiative imaging probes to radiation-emitting variants to facilitate experimental transition from bench-top to in-vivo models.

MCIF services include:
  • Radiolabeling consultation
  • Chelate selection and conjugation
  • Small molecule labeling
  • Biomolecule labeling
  • Nanoparticle labeling
  • Radiosynthesis automation and optimization
  • Quality control method development
  • MCIF commonly works with 11C, 18F, 64Cu, 68Ga, 89Zr, 161Tb, 177Lu, 212Pb, and 225Ac, but also routinely initiates projects with isotopes new to our facility.
Licensed isotopes (isotope-specific possession limits):
3H, 11C, 14C, 13N, 15O, 18F, 32P, 35S, 36Cl, 45Ca, 51Cr, 52Fe, 57,60Co, 60,61,64Cu, 65Zn, 66,68Ga, 68Ge, 82Rb, 82Sr, 86Y, 89Zr, 99Mo, 99mTc, 111In, 124,125,131I, 133Ba, 133Xe, 137Cs, 166Ho, 177Lu, 191Os, 191mIr, 198Au, 223Ra, 225Ac - 300mCi limit for other unsealed isotopes w/atomic # 3-83 with T1/2 ≤120d

Price list:
Please log in or create a new account to access our iLabs ordering site in order to view our price list and request more information about your project request.

 HOME | FACILITIES | SERVICES | NEWS AND EVENTS | PEOPLE | CONTACT US

©2022 MCIF at Dana-Farber Cancer Institute
  • Home
  • Facilities
  • Services
  • NEWS AND EVENTS
  • People
  • Contact us